Chapter
New Therapeutic Frontier for Mental Illness
49:28 - 58:18 (08:49)
The mental health crisis has been prevalent; however, there hasn't been any real innovation in mental health care since the introduction of antidepressants in 1990. The use of psychedelics to alleviate depression, anxiety, addiction, and various other disorders is the latest therapy, showing higher rates of efficacy than traditional methods.
Clips
Psychedelic experiences can reinforce ideas we already know, but only exist on the surface level of our consciousness.
49:28 - 51:13 (01:44)
Summary
Psychedelic experiences can reinforce ideas we already know, but only exist on the surface level of our consciousness. The ability to set these ideas deep in our subconscious can lead to transformative moments that allow us to truly believe in them.
ChapterNew Therapeutic Frontier for Mental Illness
Episode#313: Michael Pollan — Exploring The New Science of Psychedelics
PodcastThe Tim Ferriss Show
The current mental health care system is failing to treat the rising rates of depression, suicide, and addiction, but the introduction of psychedelics as treatment could be a breakthrough innovation.
51:13 - 52:59 (01:45)
Summary
The current mental health care system is failing to treat the rising rates of depression, suicide, and addiction, but the introduction of psychedelics as treatment could be a breakthrough innovation. Potential applications include the treatment of opiate addiction, and the use of psychedelics will be a critical addition to the field of mental health.
ChapterNew Therapeutic Frontier for Mental Illness
Episode#313: Michael Pollan — Exploring The New Science of Psychedelics
PodcastThe Tim Ferriss Show
Research has shown that psychedelics such as psilocybin and ibogaine may be useful in the treatment of depression and anxiety, with statistically significant reductions in symptoms reported in around 80% of cases.
53:00 - 56:17 (03:16)
Summary
Research has shown that psychedelics such as psilocybin and ibogaine may be useful in the treatment of depression and anxiety, with statistically significant reductions in symptoms reported in around 80% of cases. This is a promising area of research as there are few alternatives in the pipeline and existing medications such as SSRIs are losing effectiveness over time.
ChapterNew Therapeutic Frontier for Mental Illness
Episode#313: Michael Pollan — Exploring The New Science of Psychedelics
PodcastThe Tim Ferriss Show